Prostate Cancer - Results from #1080

Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort. April 12, 2024

Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool. April 12, 2024

Online decision aid for patients with prostate cancer evaluated by 11 290 patients and 91 urologists in Germany. April 12, 2024

Intraoperative Performance of DaVinci Versus Hugo RAS During Radical Prostatectomy: Focus on Timing, Malfunctioning, Complications, and User Satisfaction in 100 Consecutive Cases (the COMPAR-P Trial). April 11, 2024

ZNF397 Deficiency Triggers TET2-driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer. April 11, 2024

CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors. April 11, 2024

Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study. April 11, 2024

Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047]. April 11, 2024

Predictive Models for Assessing Patients' Response to Treatment in Metastatic Prostate Cancer: A Systematic Review. April 11, 2024

Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging. April 10, 2024

Intra-fractional geometric and dose/volume metric variations of magnetic resonance imaging-guided stereotactic radiotherapy of prostate bed after radical prostatectomy. April 10, 2024

Exploring Unmet Needs in Prostate Cancer Care: A Cross-sectional Descriptive Study. April 10, 2024

Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study. April 10, 2024

Current Systemic Therapy in Men with Metastatic Castration-Sensitive Prostate Cancer. April 10, 2024

Unmet Sexual Health Needs of Patients and Female Partners Following Diagnosis and Treatment for Prostate Cancer. April 10, 2024

Survivorship concerns among individuals diagnosed with metastatic cancer: Findings from the Cancer Experience Registry. April 10, 2024

Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval April 9, 2024

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer April 9, 2024

Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study April 9, 2024

Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. April 9, 2024

Page 55 of 1436